FXAIX
Price
$264.80
Change
+$0.34 (+0.13%)
Updated
Jun 2 closing price
Net Assets
832.15B
JNGIX
Price
$79.30
Change
+$0.21 (+0.27%)
Updated
Jun 2 closing price
Net Assets
8.31B
Interact to see
Advertisement

FXAIX vs JNGIX

Header iconFXAIX vs JNGIX Comparison
Open Charts FXAIX vs JNGIXBanner chart's image
FXAIX vs JNGIX Comparison Chart in %
View a ticker or compare two or three
VS
FXAIX vs. JNGIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and JNGIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 832B vs. JNGIX (8.31B). FXAIX pays higher dividends than JNGIX: FXAIX (1.03) vs JNGIX (0.57). FXAIX was incepted earlier than JNGIX: FXAIX (15 years) vs JNGIX (35 years). JNGIX (0.74) is less costly to investors than FXAIX (0.01). JNGIX is a more actively managed with annual turnover of: 39.00 vs. FXAIX (3.00). FXAIX has a lower initial minimum investment than JNGIX: FXAIX (0) vs JNGIX (2500). FXAIX annual gain was more profitable for investors over the last year : 29.57 vs. JNGIX (11.44). FXAIX return over 5 years is better than : 94.64 vs. JNGIX (15.60).
FXAIXJNGIXFXAIX / JNGIX
Total Expense Ratio0.010.742%
Annual Report Gross Expense Ratio0.010.742%
Fund Existence15 years35 years-
Gain YTD11.56210.175114%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets832B8.31B10,010%
Annual Yield % from dividends1.030.57180%
Returns for 1 year29.5711.44259%
Returns for 3 years84.7319.79428%
Returns for 5 years94.6415.60607%
Returns for 10 years301.4699.78302%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FADCX28.41N/A
N/A
Fidelity Advisor Diversified Intl C
SBHIX25.21N/A
N/A
Saratoga Health & Biotechnology I
CHDEX13.95N/A
N/A
Cullen High Dividend Equity Retail
KGDCX20.88N/A
N/A
DWS Global Small Cap C
LAFSX21.79N/A
N/A
Lord Abbett Affiliated R4